Whooping cough cases are rising, and doctors are bracing for yet another tough year.
Exosome-based combination therapy shows promise for treatment of metabolically challenging disease MASH
DGIST Department of New Biology Professor Yea Kyungmoo and his research team have developed a next-generation exosome-based drug-delivery technology to effectively treat metabolic dysfunction-associated steatohepatitis (MASH), an incurable metabolic disease, in collaboration with Professor Baek Moon-chang of Kyungpook National University School of Medicine.
Q&A: Researchers discuss how IV magnesium reduces kidney damage from cisplatin chemotherapy
Shruti Gupta, MD, MPH, and David Leaf, MD, MMSc, of the Renal Division, Department of Medicine at Brigham and Women’s Hospital are the first and senior authors, respectively, of a paper published in JAMA Oncology, “Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury: A Multicenter Cohort Study.”
For colon cancer that no longer responds to treatment, a new drug combination offers hope
A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped responding to chemotherapy, according to a Phase 3 clinical trial by researchers at City of Hope.
Medically tailored meals improve nutrition, reduce readmissions for heart failure patients
A study published in BMC Nutrition demonstrates that providing medically tailored meals (MTM) to patients with heart failure (HF) and malnutrition risk following hospital discharge significantly improves their nutritional status and keeps hospital readmission rates well below local and national averages.
The effects of smoking, drinking and lack of exercise are felt by the age of 36, new research indicates
Bad habits such as smoking, heavy drinking and lack of exercise must be tackled as early as possible to boost the odds of a happy and healthy old age.
Can technology transform health science? The promise of exposomics
Every breath we take, every meal we eat, and every environment we encounter leaves a molecular fingerprint in our bodies—a hidden record of our lifelong exposures. In this week’s edition of the journal Science, leading researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine. The scientists lay out a roadmap to overcome technical and logistical challenges and realize the field’s full potential.
Runner’s gut: Why some marathon runners find themselves sprinting to the toilet instead of the finish line
Running a marathon is no small feat. Athletes can expect to cover between 50-60,000 steps, burn over 3,000 calories and expel multiple liters of sweat to keep cool.
US births barely rise in 2024
Fewer babies are being born in the U.S., and experts are worried what that portends for the future.
New method improves survival analysis power in clinical and epidemiological studies
The restricted mean survival time (RMST) analysis technique was introduced in health care research about 25 years ago and since then has become widely used in economics, engineering, business and other professions.